Colorado med spa & injectable regulations
What’s changing for med spas and injectors in Colorado — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in Colorado. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.
Opening a med spa? We have not verified Colorado’s rules against the statute yet, so start with what opening a med spa requires →
Latest Colorado changes
- MONITORLegiScanApr 23, 2026
CO SB130: Medical Spas Deceptive Trade Practices
Colorado SB130 — pending bill on med-spa trade practices. Tracking.
- CRITICALLegiScanApr 7, 2025
CO HB1024: Medical-Aesthetic Services Delegation Disclosures
New disclosure requirements for delegating medical-aesthetic services.
Federal changes that apply in Colorado
FDA and Federal Register actions are nationwide — they govern Colorado practices too.
- CAUTIONFEDERALFederal RegisterJul 30, 2026
FDA / Federal Register Notice: Outsourcing Facility Fee Rates for Fiscal Year 2027
New FDA fees for outsourcing facilities will impact med spas using compounds.
- CRITICALFEDERALFDA Warning LetterJul 8, 2026
FDA Warning Letter: Spa De Soleil, Inc. (Drugs)
FDA warns Spa De Soleil over drug compounding practices.
- MONITORFEDERALFederal RegisterJun 26, 2026
FDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period
FDA extends comment period on GLP-1 compounding decisions.
- CRITICALFEDERALFDA Warning LetterJun 23, 2026
FDA Warning Letter: ketaminelab.org (Drugs)
FDA Warning Letter issued to ketaminelab.org for drugs.
- CRITICALFEDERALFTC EnforcementJun 12, 2026
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC targets deceptive health claims affecting aesthetic practices.
- CAUTIONFEDERALFDA Drug ShortagesJun 11, 2026
FDA shortage: Liraglutide Injection (Injection) — Currently in Shortage
Liraglutide is still on the FDA shortage list for compounding.
What we monitor in Colorado
- Colorado legislature — bills on injectables, GLP-1s & scope of practice
- Colorado Board of Nursing — injector scope & delegation
- Colorado Medical Board — physician supervision & ownership rules
- Colorado Board of Pharmacy — compounding & 503A/503B
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
Colorado med spa compliance — FAQ
- Where do Colorado med spa and injectable regulations come from?
- Colorado med spas and injectors are governed by a mix of state and federal authorities — the Colorado legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for Colorado and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in Colorado?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in Colorado. We track those federal changes alongside any Colorado-specific rules so you see the full picture for your practice.
- How do I keep up with Colorado regulatory changes?
- Med Spa Radar sends a free weekly Brief on what changed across Colorado, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.
Get Colorado changes as they publish
We scan the Colorado legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All states · Regulatory monitoring, not legal advice.